Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

1.14
Delayed Data
As of Dec 09
 -0.06 / -5.00%
Today’s Change
1.10
Today|||52-Week Range
15.50
-88.48%
Year-to-Date

Today’s Trading

Previous close1.20
Today’s open1.16
Day’s range1.14 - 1.23
Volume117,142
Average volume (3 months)91,420
Market cap$8.8M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)+61.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.74%
P/E ratioNM
Price/Sales10.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OPXAOpexa Therapeutics I...+0.35+40.70%
BSPMBiostar Pharmaceutic...+0.12+3.82%
CLRBCellectar Bioscience...-0.04-2.92%
CBIOCatalyst Biosciences...+0.03+3.83%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.0M
Net profit margin-393.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs